Skip to main content
Erschienen in: Strahlentherapie und Onkologie 6/2019

10.04.2019 | Case Study

Retroperitoneal soft tissue sarcoma: low-dose neoadjuvant radiation therapy followed by surgery with or without intraoperative radiotherapy and adjuvant radiation therapy

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

We describe the clinical history, outcome, and toxicity of five patients with high-grade retroperitoneal soft tissue sarcoma (RSTS) who were treated with neoadjuvant low-dose radiotherapy (RT) followed by resection with or without intraoperative radiotherapy (IORT), followed by adjuvant RT. We aim to provide additional evidence for the various treatment options that exist for this rare tumor entity.

Methods

Most patients presented with mild abdominal symptoms. Diagnosis was confirmed by biopsy. Additional imaging was done by sonography, magnetic resonance imaging (MRI), and/or positron emission tomography (PET)/computed tomography (CT). All patients were treated with neoadjuvant RT of 19.8 Gy in 1.8-Gy fractions followed by resection and postoperative RT up to 45 Gy with a median interval between resection and start of postoperative RT of 5 weeks. Two patients received additional IORT. Median follow-up was 61 months.

Results

One patient developed a local recurrence that was diagnosed 30 months after the start of the first therapy. He was treated with a salvage resection and had no evidence of disease at the last follow-up. Another patient developed a right-sided RSTS on the contralateral side from the primary radiation field with pelvic bone infiltration 56 months after the start of RT. He was treated again by RT and resection and was without evidence of disease at last follow-up. Radiotherapy was well tolerated without major toxicity.

Conclusion

The treatment of RSTS by low-dose neoadjuvant RT, resection with IORT and adjuvant RT seems to be a feasible and effective treatment approach. Further studies comparing neoadjuvant with adjuvant RT are necessary to find the best treatment option.
Literatur
1.
Zurück zum Zitat Porter GA, Baxter NN, Pisters PW (2006) Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy. Cancer 106(7):1CrossRef Porter GA, Baxter NN, Pisters PW (2006) Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy. Cancer 106(7):1CrossRef
2.
Zurück zum Zitat Catton CN, O’Sullivan B, Kotwall C et al (1994) Outcome and prognosis in retroperitoneal sarcoma. Int J Radiat Oncol Biol Phys 29:1005–1010CrossRefPubMed Catton CN, O’Sullivan B, Kotwall C et al (1994) Outcome and prognosis in retroperitoneal sarcoma. Int J Radiat Oncol Biol Phys 29:1005–1010CrossRefPubMed
3.
Zurück zum Zitat Stoeckle E, Coindre JM, Bonvalot S, Kantor G, Terrier P, Bonichon F, Nguyen Bui B (2001) French Federation of Cancer Centers Sarcoma Group. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 92(2):359–368CrossRefPubMed Stoeckle E, Coindre JM, Bonvalot S, Kantor G, Terrier P, Bonichon F, Nguyen Bui B (2001) French Federation of Cancer Centers Sarcoma Group. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 92(2):359–368CrossRefPubMed
4.
Zurück zum Zitat Singer S, Antonescu CR, Riedel E, Brennan MF (2003) Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg 238(3):358–370PubMedPubMedCentral Singer S, Antonescu CR, Riedel E, Brennan MF (2003) Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg 238(3):358–370PubMedPubMedCentral
5.
Zurück zum Zitat Heslin MJ, Lewis JJ, Nadler E, Newman E, Woodruff JM, Casper ES, Leung D, Brennan MF (1997) Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol 15(8):2832–2839CrossRefPubMed Heslin MJ, Lewis JJ, Nadler E, Newman E, Woodruff JM, Casper ES, Leung D, Brennan MF (1997) Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol 15(8):2832–2839CrossRefPubMed
6.
Zurück zum Zitat Choi AH, Barnholtz-Sloan JS, Kim JA (2012) Effect of radiation therapy on survival in surgically resected retroperitoneal sarcoma: a propensity score-adjusted SEER analysis. Ann Oncol 23(9):2449–2457CrossRefPubMedPubMedCentral Choi AH, Barnholtz-Sloan JS, Kim JA (2012) Effect of radiation therapy on survival in surgically resected retroperitoneal sarcoma: a propensity score-adjusted SEER analysis. Ann Oncol 23(9):2449–2457CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Mendenhall WM, Zlotecki RA, Hochwald SN, Hemming AW, Grobmyer SR, Cance WG (2005) Retroperitoneal soft tissue sarcoma. Cancer 104(4):669–675CrossRefPubMed Mendenhall WM, Zlotecki RA, Hochwald SN, Hemming AW, Grobmyer SR, Cance WG (2005) Retroperitoneal soft tissue sarcoma. Cancer 104(4):669–675CrossRefPubMed
8.
Zurück zum Zitat Stoeckle E, Coindre JM, Bonvalot S et al (2001) Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 92:359–368CrossRefPubMed Stoeckle E, Coindre JM, Bonvalot S et al (2001) Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 92:359–368CrossRefPubMed
9.
Zurück zum Zitat Van De Voorde L, Delrue L, van Eijkeren M, De Meerleer G (2011) Radiotherapy and surgery-an indispensable duo in the treatment of retroperitoneal sarcoma. Cancer 117(19):4355–4364CrossRef Van De Voorde L, Delrue L, van Eijkeren M, De Meerleer G (2011) Radiotherapy and surgery-an indispensable duo in the treatment of retroperitoneal sarcoma. Cancer 117(19):4355–4364CrossRef
10.
Zurück zum Zitat Gronchi A, Lo Vullo S, Fiore M et al (2009) Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol 27:24–30CrossRefPubMed Gronchi A, Lo Vullo S, Fiore M et al (2009) Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol 27:24–30CrossRefPubMed
11.
Zurück zum Zitat Lane WO, Cramer CK, Nussbaum DP et al (2015) Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma. J Surg Oncol 112:352–358CrossRefPubMed Lane WO, Cramer CK, Nussbaum DP et al (2015) Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma. J Surg Oncol 112:352–358CrossRefPubMed
12.
Zurück zum Zitat Nussbaum DP, Rushing CN, Lane WO, Cardona DM, Kirsch DG, Peterson BL, Blazer DG 3rd (2016) Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database. Lancet Oncol 17(7):966–975CrossRefPubMed Nussbaum DP, Rushing CN, Lane WO, Cardona DM, Kirsch DG, Peterson BL, Blazer DG 3rd (2016) Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database. Lancet Oncol 17(7):966–975CrossRefPubMed
13.
Zurück zum Zitat Nielsen OS, O’Sullivan B (2002) Retroperitoneal soft tissue sarcomas: a treatment challenge and a call for randomized trials. Radiother Oncol 65(3):133–136CrossRefPubMed Nielsen OS, O’Sullivan B (2002) Retroperitoneal soft tissue sarcomas: a treatment challenge and a call for randomized trials. Radiother Oncol 65(3):133–136CrossRefPubMed
14.
Zurück zum Zitat Nussbaum DP, Speicher PJ, Gulack BC, Ganapathi AM, Englum BR, Kirsch DG, Tyler DS, Blazer DG 3rd (2015) Long-term oncologic outcomes after neoadjuvant radiation therapy for Retroperitoneal sarcomas. Ann Surg 262(1):163–170CrossRefPubMedPubMedCentral Nussbaum DP, Speicher PJ, Gulack BC, Ganapathi AM, Englum BR, Kirsch DG, Tyler DS, Blazer DG 3rd (2015) Long-term oncologic outcomes after neoadjuvant radiation therapy for Retroperitoneal sarcomas. Ann Surg 262(1):163–170CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Pawlik TM, Pisters PW, Mikula L, Feig BW, Hunt KK, Cormier JN, Ballo MT, Catton CN, Jones JJ, O’Sullivan B, Pollock RE, Swallow CJ (2006) Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol 13(4):508–517CrossRefPubMed Pawlik TM, Pisters PW, Mikula L, Feig BW, Hunt KK, Cormier JN, Ballo MT, Catton CN, Jones JJ, O’Sullivan B, Pollock RE, Swallow CJ (2006) Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol 13(4):508–517CrossRefPubMed
16.
Zurück zum Zitat Yoon SS, Chen YL, Kirsch DG, Maduekwe UN, Rosenberg AE, Nielsen GP, Sahani DV, Choy E, Harmon DC, DeLaney TF (2010) Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas. Ann Surg Oncol 17(6):1515–1529CrossRefPubMedPubMedCentral Yoon SS, Chen YL, Kirsch DG, Maduekwe UN, Rosenberg AE, Nielsen GP, Sahani DV, Choy E, Harmon DC, DeLaney TF (2010) Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas. Ann Surg Oncol 17(6):1515–1529CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Zlotecki RA, Katz TS, Morris CG, Lind DS, Hochwald SN (2005) Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma: the University of Florida experience. Am J Clin Oncol 28(3):310–316CrossRefPubMed Zlotecki RA, Katz TS, Morris CG, Lind DS, Hochwald SN (2005) Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma: the University of Florida experience. Am J Clin Oncol 28(3):310–316CrossRefPubMed
18.
Zurück zum Zitat O’Sullivan B, Davis AM, Turcotte R, Bell R, Catton C, Chabot P, Wunder J, Kandel R, Goddard K, Sadura A, Pater J, Zee B (2002) Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 359(9325):2235–2241CrossRefPubMed O’Sullivan B, Davis AM, Turcotte R, Bell R, Catton C, Chabot P, Wunder J, Kandel R, Goddard K, Sadura A, Pater J, Zee B (2002) Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 359(9325):2235–2241CrossRefPubMed
19.
Zurück zum Zitat Kunisada T, Ngan SY, Powell G (2002) et al. Wound complications following pre-operative radiotherapy for soft tissue sarcoma. Eur J Surg Oncol 28:75–79CrossRefPubMed Kunisada T, Ngan SY, Powell G (2002) et al. Wound complications following pre-operative radiotherapy for soft tissue sarcoma. Eur J Surg Oncol 28:75–79CrossRefPubMed
20.
Zurück zum Zitat Cannon CP, Ballo MT, Zagars GK (2006) et al. Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas. Cancer 107:2455–2461CrossRefPubMed Cannon CP, Ballo MT, Zagars GK (2006) et al. Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas. Cancer 107:2455–2461CrossRefPubMed
21.
Zurück zum Zitat Devisetty K, Kobayashi W, Suit HD, Goldberg SI, Niemierko A, Chen YL, Raskin KA, Schwab JH, Springfield DS, Yoon SS, Hornicek FJ, DeLaney TF (2011) Low-dose neoadjuvant external beam radiation therapy for soft tissue sarcoma. Int J Radiat Oncol Biol Phys 80(3):779–786CrossRefPubMed Devisetty K, Kobayashi W, Suit HD, Goldberg SI, Niemierko A, Chen YL, Raskin KA, Schwab JH, Springfield DS, Yoon SS, Hornicek FJ, DeLaney TF (2011) Low-dose neoadjuvant external beam radiation therapy for soft tissue sarcoma. Int J Radiat Oncol Biol Phys 80(3):779–786CrossRefPubMed
22.
Zurück zum Zitat Fletcher CDM, Unni KK, Mertens F (eds) (2002) Pathology and genetics of tumours of soft tissue and Bone. World Health Organization Classification of Tumours, vol 5. IARC Press, Lyon Fletcher CDM, Unni KK, Mertens F (eds) (2002) Pathology and genetics of tumours of soft tissue and Bone. World Health Organization Classification of Tumours, vol 5. IARC Press, Lyon
23.
Zurück zum Zitat Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, CARE Group (2014) The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol 67(1):46–51CrossRefPubMed Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, CARE Group (2014) The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol 67(1):46–51CrossRefPubMed
24.
Zurück zum Zitat Alldinger I, Yang Q, Pilarsky C, Saeger HD, Knoefel WT, Peiper M (2006) Retroperitoneal soft tissue sarcomas: prognosis and treatment of primary and recurrent disease in 117 patients. Anticancer Res 26(2B):1577–1581PubMed Alldinger I, Yang Q, Pilarsky C, Saeger HD, Knoefel WT, Peiper M (2006) Retroperitoneal soft tissue sarcomas: prognosis and treatment of primary and recurrent disease in 117 patients. Anticancer Res 26(2B):1577–1581PubMed
25.
Zurück zum Zitat Dunst J (2016) (2016) [Pre- or postoperative radiotherapy essential for the treatment of retroperitoneal sarcomas. Strahlenther Onkol 192(11):820–822CrossRefPubMed Dunst J (2016) (2016) [Pre- or postoperative radiotherapy essential for the treatment of retroperitoneal sarcomas. Strahlenther Onkol 192(11):820–822CrossRefPubMed
26.
Zurück zum Zitat Pollack A, Zagars GK, Goswitz MS et al (1998) Preoperative vs. postoperative radiotherapy in the treatment of soft tissue sarcomas: A matter of presentation. Int J Radiat Oncol Biol Phys 42:563–572CrossRefPubMed Pollack A, Zagars GK, Goswitz MS et al (1998) Preoperative vs. postoperative radiotherapy in the treatment of soft tissue sarcomas: A matter of presentation. Int J Radiat Oncol Biol Phys 42:563–572CrossRefPubMed
27.
Zurück zum Zitat Kunisada T, Ngan SY, Powell G et al (2002) Wound complications following pre-operative radiotherapy for soft tissue sarcoma. Eur J Surg Oncol 28:75–79CrossRefPubMed Kunisada T, Ngan SY, Powell G et al (2002) Wound complications following pre-operative radiotherapy for soft tissue sarcoma. Eur J Surg Oncol 28:75–79CrossRefPubMed
28.
Zurück zum Zitat Wijnmaalen A, van der Werf-Messing BH (1986) Factors influencing the prognosis in bladder cancer. Int J Radiat Oncol Biol Phys 12:559–565CrossRefPubMed Wijnmaalen A, van der Werf-Messing BH (1986) Factors influencing the prognosis in bladder cancer. Int J Radiat Oncol Biol Phys 12:559–565CrossRefPubMed
29.
Zurück zum Zitat Gerhards MF, Gonzalez DG, ten Hoopen-Neumann H et al (2000) Prevention of implantation metastases after resection of proximal bile duct tumours with pre-operative low dose radiation therapy. Eur J Surg Oncol 26:480–485CrossRefPubMed Gerhards MF, Gonzalez DG, ten Hoopen-Neumann H et al (2000) Prevention of implantation metastases after resection of proximal bile duct tumours with pre-operative low dose radiation therapy. Eur J Surg Oncol 26:480–485CrossRefPubMed
30.
Zurück zum Zitat Casali PG et al (2018) Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29(Suppl 4):iv268–iv269CrossRefPubMed Casali PG et al (2018) Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29(Suppl 4):iv268–iv269CrossRefPubMed
31.
Zurück zum Zitat Baldini EH, Abrams RA, Bosch W, Roberge D, Haas RL, Catton CN, Indelicato DJ, Olsen JR, Deville C, Chen YL, Finkelstein SE, DeLaney TF, Wang D (2015) Retroperitoneal sarcoma target volume and organ at risk contour delineation agreement among NRG sarcoma radiation Oncologists. Int J Radiat Oncol Biol Phys 92(5):1053–1059CrossRefPubMedPubMedCentral Baldini EH, Abrams RA, Bosch W, Roberge D, Haas RL, Catton CN, Indelicato DJ, Olsen JR, Deville C, Chen YL, Finkelstein SE, DeLaney TF, Wang D (2015) Retroperitoneal sarcoma target volume and organ at risk contour delineation agreement among NRG sarcoma radiation Oncologists. Int J Radiat Oncol Biol Phys 92(5):1053–1059CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Baldini EH, Wang D, Haas RL, Catton CN, Indelicato DJ, Kirsch DG, Roberge D, Salerno K, Deville C, Guadagnolo BA, O’Sullivan B, Petersen IA, Le Pechoux C, Abrams RA, DeLaney TF (2015) Treatment guidelines for preoperative radiation therapy for retroperitoneal sarcoma: preliminary consensus of an international expert panel. Int J Radiat Oncol Biol Phys 92(3):602–612CrossRefPubMed Baldini EH, Wang D, Haas RL, Catton CN, Indelicato DJ, Kirsch DG, Roberge D, Salerno K, Deville C, Guadagnolo BA, O’Sullivan B, Petersen IA, Le Pechoux C, Abrams RA, DeLaney TF (2015) Treatment guidelines for preoperative radiation therapy for retroperitoneal sarcoma: preliminary consensus of an international expert panel. Int J Radiat Oncol Biol Phys 92(3):602–612CrossRefPubMed
Metadaten
Titel
Retroperitoneal soft tissue sarcoma: low-dose neoadjuvant radiation therapy followed by surgery with or without intraoperative radiotherapy and adjuvant radiation therapy
Publikationsdatum
10.04.2019
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 6/2019
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-019-01464-3

Weitere Artikel der Ausgabe 6/2019

Strahlentherapie und Onkologie 6/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.